Evidence map›Paper›PMID 28840137›Full record

ArticleAsia Oceania journal of nuclear medicine & biology2017

Uptake Index of

Yoshito Kamiya, Satoru Ota, Shintaro Okumiya, Kosuke Yamashita, Akihiro Takaki, Shigeki Ito

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Asia Oceania journal of nuclear medicine & biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Development of anAsia Oceania journal of nuclear medicine & biology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yoshito KamiyaGraduate School of Health Sciences, Kumamoto University, Kumamoto, Japan.
Satoru OtaGraduate School of Health Sciences, Kumamoto University, Kumamoto, Japan.
Shintaro OkumiyaGraduate School of Health Sciences, Kumamoto University, Kumamoto, Japan.
Kosuke YamashitaFaculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Akihiro TakakiDepartment of Medical Imaging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Shigeki ItoDepartment of Medical Imaging, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Kumamoto University · JPKumamoto Health Science University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIodine-123 metaiodobenzylguanidine (

methodsThe

resultsForty-eight patients underwent

conclusionA simple uptake index method was developed using

Indexed as

Iodine-123 metaiodobenzylguanidineLewy body diseaseQuantificationUptake index

Identifiers

PMID28840137
PMCPMC5221684
OpenAlexW2584854141

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.